News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
419,095 Results
Type
Article (33981)
Company Profile (87)
Press Release (385027)
Section
Business (121715)
Career Advice (1374)
Deals (25061)
Drug Delivery (93)
Drug Development (62487)
Employer Resources (104)
FDA (10430)
Job Trends (9580)
News (225036)
Policy (26479)
Tag
Academia (1951)
Alliances (43536)
Alzheimer's disease (1002)
Approvals (10358)
Artificial intelligence (87)
Bankruptcy (232)
Best Places to Work (7895)
Biosimilars (67)
Biotechnology (65)
Breast cancer (78)
Cancer (715)
Career advice (1151)
Cell therapy (157)
Clinical research (49072)
Collaboration (272)
Compensation (127)
COVID-19 (2457)
Data (637)
Diabetes (112)
Diagnostics (3592)
Drug pricing (80)
Earnings (41651)
Employer resources (96)
Events (49679)
Executive appointments (119)
FDA (10762)
Funding (201)
Gene therapy (129)
GLP-1 (560)
Government (4097)
Healthcare (11957)
Infectious disease (2532)
Inflammatory bowel disease (75)
Interviews (235)
IPO (10813)
Job creations (1923)
Job search strategy (999)
Layoffs (271)
Legal (7066)
Lung cancer (131)
Manufacturing (136)
Medical device (6446)
Medtech (6448)
Mergers & acquisitions (14279)
Metabolic disorders (326)
Neuroscience (1197)
NextGen Class of 2024 (3881)
Non-profit (2898)
Northern California (820)
Obesity (199)
Opinion (173)
Patents (76)
People (28286)
Phase I (14930)
Phase II (21307)
Phase III (17151)
Pipeline (157)
Policy (66)
Postmarket research (1888)
Preclinical (6234)
Press Release (68)
Radiopharmaceuticals (198)
Rare diseases (140)
Real estate (3062)
Regulatory (16425)
Research institute (1707)
Resumes & cover letters (203)
Southern California (711)
Startups (2109)
United States (7139)
Vaccines (572)
Weight loss (170)
Date
Last 7 days (516)
Last 30 days (1771)
Last 365 days (24554)
2024 (20670)
2023 (27305)
2022 (35965)
2021 (38702)
2020 (36359)
2019 (29831)
2018 (22677)
2017 (21919)
2016 (20419)
2015 (23460)
2014 (17499)
2013 (14126)
2012 (14915)
2011 (15714)
2010 (14181)
Location
Africa (593)
Arizona (67)
Asia (27550)
Australia (4791)
California (1757)
Canada (742)
China (163)
Colorado (68)
Connecticut (67)
Europe (64515)
Florida (249)
Georgia (60)
Illinois (172)
Indiana (113)
Maryland (388)
Massachusetts (1292)
Michigan (71)
Minnesota (105)
New Jersey (598)
New York (576)
North Carolina (379)
Northern California (820)
Ohio (76)
Pennsylvania (454)
South America (830)
Southern California (711)
Texas (216)
Washington State (185)
419,095 Results for "apeiron biologics ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
News
BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting
August 27, 2024
·
11 min read
Business
Alamar Biosciences and Biomarkers of Aging Consortium Join Forces to Revolutionize Longevity Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium announced the launch of the next phase of the Biomarkers of Aging Challenge Series.
June 27, 2024
·
3 min read
Approvals
AstraZeneca Wins Rare Autoimmune Indication for Asthma Biologic Fasenra
With the FDA’s approval, Fasenra will compete with GSK’s Nucala, which in December 2017 became the first biologic approved for eosinophilic granulomatosis with polyangiitis.
September 19, 2024
·
2 min read
·
Tristan Manalac
Business
RevOpsis and Kemwell Biopharma Enter into Strategic Manufacturing Partnership to Expedite Development of Novel Multispecific Biologics
RevOpsis Therapeutics and Kemwell Biopharma announced today a broad strategic manufacturing partnership. This collaboration aims to accelerate the development of RevOpsis’ lead candidate, RO-104, a first-in-class tri-specific biologic for the treatment of neovascular age-related macular degeneration (nAMD).
June 17, 2024
·
5 min read
GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report
Sirona Biochem Corp. is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare’s newly published research report, “Novel Treatments for Age-Related Skin Problems.” The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market.
June 18, 2024
·
3 min read
News
Webinar: Revolutionizing Biologics Discovery: Harnessing the Power of AI and Patent Data
This webinar explores the pivotal role of patent data in overcoming the data challenges faced by generative AI models in drug discovery, particularly for biologics. Watch now.
October 23, 2024
·
1 min read
·
BioSpace Insights
Press Releases
Medigene AG reports Financial Results and Business Update for Q3 2024
October 24, 2024
·
6 min read
BioMidwest
Epigenetic laboratory TruDiagnostic launches first ever organ-specific aging analysis from Yale-developed SYMPHONYAge algorithms
Marking a milestone development in epigenetic research and clinical health applications, laboratory TruDiagnostic is launching the first ever, epigenetic aging analysis of individual organ systems, using validated and system-specific trained clocks.
June 28, 2024
·
4 min read
1 of 41,910
Next